China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2007, 2012 and 2017) and long-term forecasts through 2022 and 2027 are presented. Major producers in China are profiled.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.
Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.
TABLE OF CONTENTS
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS
Blood Disease Drugs Industry Structure
Market Size
Market Growth Drivers
Blood Disease Drugs Sales Volume
Major Producer Facility Locations and Sales Volume
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
Overview
Demand of Blood Disease Drugs by Region
Blood Disease Drugs Sales Volume
Anemia Treatment Drugs
Mecobalamin
Cobamamide
Ferrous Succinate
Leucogen
Neutropenia and Agranulocytosis Treatment Drugs
VitamineB4
Batilol
Inosine
Deoxyribonucleotide
Adrenocortical Hormone
Granulocyte Colony-Stimulating Factor(G-CSF)
Leukemia Treatment Drugs Sales Volume
Interferon
Imatinib
Rituximab
Pirarubicin
Hydroxycampothecin
Other Blood Disease Drugs Sales Volume
Blood Disease Drugs Imports
Anemia Treatment Drugs
Mecobalamin
Cobamamide
Ferrous Succinate
Leucogen
Neutropenia and Agranulocytosis Treatment Drugs Imports
VitamineB4
Batilol
Inosine
Deoxyribonucleotide
Adrenocortical Hormone
Granulocyte Colony-Stimulating Factor(G-CSF)
Leukemia Treatment Drugs Imports
Interferon
Imatinib
Rituximab
Pirarubicin
Hydroxycampothecin
Other Blood Disease Drugs Imports
Pricing Trends
V. BLOOD DISEASE DRUGS MARKET OUTLOOK
Blood Disease Drugs Market Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Northeast
North
Southeast
Central
Southwest
Northwest
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
VI. MARKETING STRATEGIES
China Market Entry Overview
China's Distribution System
Rubber Processing Chemicals Distribution Channels
Transportation and Freight Infrastructure
Communications
China’s Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises
VII. BLOOD DISEASE DRUGS PRODUCER DIRECTORY
Blood Disease Drugs Producer Profiles
Distributors and Trading Companies
Research Institutions and Associations
ULIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS
Anemia Treatment Drugs Sales Volume by Drugs Classification
Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
Leukemia Treatment Drugs Sales Volume by Drugs Classification
Blood Disease Drugs Sales Volume
Major Producer Facility Location
Major Blood Disease Drugs Producer Sales Volume
Market Share of Key Producers
Major Foreign Investment in China
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
Total Blood Disease Drugs Sales Volume
Blood Disease Drugs Major Producer and Their Market Share
Anemia Major Producer and Their Market Share
Anemia Treatment Drugs Sales Volume by Drugs Classification
Anemia Treatment Drugs Major Producer and Their Market Share
Mecobalamin Major Producer and Their Market Share
Cobamamide Major Producer and Their Market Share
Ferrous Succinate Major Producer and Their Market Share
Leucogen Major Producer and Their Market Share
Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share
Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
VitamineB4 Major Producer and Their Market Share
Batilol Major Producer and Their Market Share
Inosine Major Producer and Their Market Share
Deoxyribonucleotide Major Producer and Their Market Share
Adrenocortical Hormone Major Producer and Their Market Share
Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share
Leukemia Treatment Drugs Major Producer and Their Market Share
Leukemia Treatment Drugs Sales Volume by Drugs Classification
Interferon Major Producers and Their Market Share
Imatinib Mesylate Major Producer and Their Market Share
Rituximab Major Producer and Their Market Share
Pirarubicin Major Producer and Their Market Share
Hydroxycampothecin Major Producer and Their Market Share
Blood Disease Drugs Import
Anemia Treatment Drugs Import Volume by Drugs Classification
Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
Leukemia Treatment Drugs Import Volume by Drugs Classification
V. BLOOD DISEASE DRUGS MARKET OUTLOOK
Consumer Spending Trend
The Structure of Per Capita Expenditure in the Northeast of China
The Structure of Per Capita Expenditure in the North of China
The Structure of Per Capita Expenditure in the Southeast of China
The Structure of Per Capita Expenditure in the Central of China
The Structure of Per Capita Expenditure in the Southwest of China
The Structure of Per Capita Expenditure in the Northwest of China
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
ULIST OF CHARTS
I. NTRODUCTION
Blood Disease Drugs Sales Volume
II. BUSINESS ENVIRONMENT
China's GDP and Industrial Output
Industrial Output by Ownership
China’s Imports and Exports
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS
Anemia Treatment Drugs Sales Volume by Drugs Classification
Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
Leukemia Treatment Drugs Sales Volume by Drugs Classification
Blood Disease Drugs Sales Volume
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
Blood Disease Drugs Sales Volume
Worldwide Blood Disease Drugs Demand by region
Anemia Major Producer and Their Market Share
Anemia Treatment Drugs Sales Volume by Drugs Classification
Mecobalamin Sales Volume and Market Share
Cobamamide Sales Volume and Market Share
Ferrous Succinate Sales Volume and Market Share
Leucogen Sales Volume and Market Share
Neutropenia and Agranulocytosis Treatment Drugs Sales Volume and Market Share
Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
VitamineB4 Sales Volume and Market Share
Batilol Sales Volume and Market Share
Inosine Sales Volume and Market Share
Deoxyribonucleotide Sales Volume and Market Share
Adrenocortical Hormone Sales Volume and Market Share
Granulocyte Colony-Stimulating Factor(G-CSF) Sales Volume and Market Share
Leukemia Treatment Drugs Sales Volume and Market Share
Leukemia Treatment Drugs Sales Volume by Drugs Classification
Interferon Sales Volume and Market Share
Imatinib Mesylate Sales Volume and Market Share
Rituximab Sales Volume and Market Share
Pirarubicin Sales Volume and Market Share
Hydroxycampothecin Sales Volume and Market Share
Other Blood Disease Drugs Sales volume and Market Share
Blood Disease Drugs Import Volume
Anemia Import Volume and Market Share
Anemia Treatment Drugs Import Volume by Drugs Classification
Mecobalamin Import Volume and Market Share
Cobamamide Import Volume and Market Share
Ferrous Succinate Import Volume and Market Share
Leucogen Import Volume and Market Share
Galanthamine Import Volume and Market Share
Neutropenia and Agranulocytosis Treatment Drugs Import Volume and Market Share
Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
VitamineB4 Import Volume and Market Share
Batilol Import Volume and Market Share
Inosine Import Volume and Market Share
Deoxyribonucleotide Import Volume and Market Share
Adrenocortical Hormone Import Volume and Market Share
Granulocyte Colony-Stimulating Factor(G-CSF) Import Volume and Market Share
Leukemia Treatment Drugs Import Volume and Market Share
Leukemia Treatment Drugs Import Volume by Drugs Classification
Interferon Treatment Drugs Import Volume and Market Share
Imatinib Mesylate Treatment Drugs Import Volume and Market Share
Rituximab Treatment Drugs Import Volume and Market Share
Pirarubicin Treatment Drugs Import Volume and Market Share
Hydroxycampothecin Treatment Drugs Import Volume and Market Share
Other Blood Disease Drugs Import Volume and Market Share
VI. MARKETING STRATEGIES
China’s Distribution Channel
